Long Term Follow-up Study for rAAv-GAD Treated Subjects.

Trial Profile

Long Term Follow-up Study for rAAv-GAD Treated Subjects.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs NLX P101 (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top